Batool S, Chokkakula S, Jeong J, Baek Y, Song M
Heliyon. 2025; 11(2):e41980.
PMID: 39897928
PMC: 11786845.
DOI: 10.1016/j.heliyon.2025.e41980.
Satoh T, Akata K, Yamasaki K, Tsuruta A, Yatera K
Cureus. 2025; 16(12):e75722.
PMID: 39816292
PMC: 11732614.
DOI: 10.7759/cureus.75722.
Bay A, Clausen M, Roge B, Sydenham T, Steinke K, Pedersen R
IDCases. 2024; 38:e02118.
PMID: 39634632
PMC: 11615917.
DOI: 10.1016/j.idcr.2024.e02118.
Nasrullah A, Shakir H, Khan E, Bilal M, Sheikh A, Malik K
J Community Hosp Intern Med Perspect. 2024; 14(5):63-72.
PMID: 39399191
PMC: 11466343.
DOI: 10.55729/2000-9666.1399.
Barnaba Durairaj M, Caraway H, Buresh R, Sampath R, Waghchoure S
Cureus. 2024; 16(5):e60328.
PMID: 38883063
PMC: 11177329.
DOI: 10.7759/cureus.60328.
A Robust Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T- and B-Cell Response Is Associated With Early Viral Clearance in SARS-CoV-2 Omicron-Infected Immunocompromised Individuals.
Vergouwe M, Biemond J, van der Straten K, van Pul L, Kerster G, Claireaux M
J Infect Dis. 2024; 230(4):e860-e871.
PMID: 38843052
PMC: 11481360.
DOI: 10.1093/infdis/jiae306.
Radiologic Abnormalities in Prolonged SARS-CoV-2 Infection: A Systematic Review.
Beck K, Yoon J, Yoon S
Korean J Radiol. 2024; 25(5):473-480.
PMID: 38685737
PMC: 11058427.
DOI: 10.3348/kjr.2023.1149.
Testing for SARS-CoV-2: lessons learned and current use cases.
Theel E, Kirby J, Pollock N
Clin Microbiol Rev. 2024; 37(2):e0007223.
PMID: 38488364
PMC: 11237512.
DOI: 10.1128/cmr.00072-23.
B-cell-depleted patients with persistent SARS-CoV-2 infection: combination therapy or monotherapy? A real-world experience.
DAbramo A, Vita S, Beccacece A, Navarra A, Pisapia R, Fusco F
Front Med (Lausanne). 2024; 11:1344267.
PMID: 38487021
PMC: 10937561.
DOI: 10.3389/fmed.2024.1344267.
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/Ritonavir.
Snell L, McGreal-Bellone A, Nye C, Gage S, Bakrania P, Williams T
Open Forum Infect Dis. 2024; 11(1):ofad612.
PMID: 38269048
PMC: 10807981.
DOI: 10.1093/ofid/ofad612.
Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID-19 infection at an ambulatory cancer center.
Sanchez E, Krantz E, Yoke L, Gallaher M, Bhattacharyya P, So L
Transpl Infect Dis. 2024; 26(1):e14223.
PMID: 38191852
PMC: 10922880.
DOI: 10.1111/tid.14223.
Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab.
Gentile I, Foggia M, Silvitelli M, Sardanelli A, Cattaneo L, Viceconte G
Virol J. 2023; 20(1):301.
PMID: 38102675
PMC: 10724917.
DOI: 10.1186/s12985-023-02269-8.
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era.
Gotz V, Mathe P, Agarwal P, Hornuss D, Pfau S, Panning M
Infection. 2023; 52(3):923-933.
PMID: 38095753
PMC: 11142974.
DOI: 10.1007/s15010-023-02138-0.
COVID-19 outcome is not affected by anti-CD20 or high-titer convalescent plasma in immunosuppressed patients.
Kasten M, Lahr B, Parisapogu A, Yetmar Z, OHoro J, Orenstein R
Sci Rep. 2023; 13(1):21249.
PMID: 38040756
PMC: 10692159.
DOI: 10.1038/s41598-023-48145-x.
Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses.
Meyerowitz E, Li Y
Clin Infect Dis. 2023; 78(4):908-917.
PMID: 37949817
PMC: 11487108.
DOI: 10.1093/cid/ciad685.
Persistent SARS-CoV-2 infection in patients with B-cell deficiency: a case series of successful antiviral treatment of four patients.
Faxen L, Edvinsson M
Ups J Med Sci. 2023; 128.
PMID: 37849689
PMC: 10578053.
DOI: 10.48101/ujms.v128.9807.
Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients.
Velez A, Handley G, Morison A, Katzman J, Kinkhova O, Quiltz R
Cancer Control. 2023; 30:10732748231205864.
PMID: 37817417
PMC: 10566286.
DOI: 10.1177/10732748231205864.
[Evaluation of two phenotypic techniques and a commercial multiplex molecular panel for the detection of different carbapenemases].
Hernando Parreno N, Sampere Martinez A
Rev Esp Quimioter. 2023; 36(6):621-624.
PMID: 37786957
PMC: 10710673.
DOI: 10.37201/req/049.2023.
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series.
Longo B, Venuti F, Gaviraghi A, Lupia T, Ranzani F, Pepe A
Antibiotics (Basel). 2023; 12(9).
PMID: 37760757
PMC: 10525462.
DOI: 10.3390/antibiotics12091460.
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort.
Grimaldi P, Russo A, Pisaturo M, Maggi P, Allegorico E, Gentile I
Infection. 2023; 52(2):439-446.
PMID: 37704910
PMC: 10954924.
DOI: 10.1007/s15010-023-02095-8.
